166 related articles for article (PubMed ID: 21684479)
1. Economic burden of gastro-oesophageal reflux disease and dyspepsia: A community-based study.
Moghimi-Dehkordi B; Vahedi M; Khoshkrood Mansoori B; Kasaeian A; Safaee A; Habibi M; Pourhoseingholi A; Pourhoseingholi MA; Zali MR
Arab J Gastroenterol; 2011 Jun; 12(2):86-9. PubMed ID: 21684479
[TBL] [Abstract][Full Text] [Related]
2. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
[TBL] [Abstract][Full Text] [Related]
3. Zero inflated statistical count models for analysing the costs imposed by GERD and dyspepsia.
Akbarzadeh Baghban A; Pourhoseingholi A; Zayeri F; Ashtari S; Zali MR
Arab J Gastroenterol; 2013 Dec; 14(4):165-8. PubMed ID: 24433646
[TBL] [Abstract][Full Text] [Related]
4. Irritable bowel syndrome, gastro-oesophageal reflux disease and dyspepsia: overlap analysis using loglinear models.
Pourhoseingholi A; Vahedi M; Pourhoseingholi MA; Ashtari S; Moghimi-Dehkordi B; Safaee A; Zali MR
Arab J Gastroenterol; 2012 Mar; 13(1):20-3. PubMed ID: 22560820
[TBL] [Abstract][Full Text] [Related]
5. The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms.
Wagner JS; DiBonaventura MD; Balu S; Buchner D
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):739-49. PubMed ID: 22098290
[TBL] [Abstract][Full Text] [Related]
6. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa.
Willich SN; Nocon M; Kulig M; Jaspersen D; Labenz J; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P
Aliment Pharmacol Ther; 2006 Feb; 23(3):371-6. PubMed ID: 16422996
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
Lee SY; Lee KJ; Kim SJ; Cho SW
Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological study of gastro-oesophageal reflux disease: reflux in spouse as a risk factor.
Nasseri-Moghaddam S; Mofid A; Ghotbi MH; Razjouyan H; Nouraie M; Ramard AR; Zaer-Rezaie H; Habibi R; Rafat-Zand K; Malekzadeh R
Aliment Pharmacol Ther; 2008 Jul; 28(1):144-53. PubMed ID: 18410559
[TBL] [Abstract][Full Text] [Related]
9. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.
Wahlqvist P; Karlsson M; Johnson D; Carlsson J; Bolge SC; Wallander MA
Aliment Pharmacol Ther; 2008 May; 27(10):960-70. PubMed ID: 18315585
[TBL] [Abstract][Full Text] [Related]
10. Gastro-oesophageal acid-related disease, co-morbidity and medical care cost.
Jayadevappa R; Chhatre S; Weiner M
Chronic Illn; 2008 Sep; 4(3):209-18. PubMed ID: 18796510
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study.
Haque M; Wyeth JW; Stace NH; Talley NJ; Green R
N Z Med J; 2000 May; 113(1110):178-81. PubMed ID: 10917077
[TBL] [Abstract][Full Text] [Related]
12. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
13. Hygiene could affect GERD prevalence independently: a population-based study in Tehran.
Nouraie M; Radmard AR; Zaer-Rezaii H; Razjouyan H; Nasseri-Moghaddam S; Malekzadeh R
Am J Gastroenterol; 2007 Jul; 102(7):1353-60. PubMed ID: 17437507
[TBL] [Abstract][Full Text] [Related]
14. Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population.
Doan QV; Lange SM; Elfant A; Aguilar D; Reyes E; Lynn RB; Dubois RW
J Med Econ; 2008; 11(1):23-40. PubMed ID: 19450108
[TBL] [Abstract][Full Text] [Related]
15. Economic burden attributable to functional bowel disorders in Iran: a cross-sectional population-based study.
Moghimi-Dehkordi B; Vahedi M; Pourhoseingholi MA; Khoshkrood Mansoori B; Safaee A; Habibi M; Pourhoseingholi A; Zali MR
J Dig Dis; 2011 Oct; 12(5):384-92. PubMed ID: 21955432
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey.
Nouraie M; Razjouyan H; Assady M; Malekzadeh R; Nasseri-Moghaddam S
Arch Iran Med; 2007 Jul; 10(3):289-94. PubMed ID: 17604463
[TBL] [Abstract][Full Text] [Related]
17. Management of gastro-oesophageal reflux disease in primary care: a European observational study.
Gisbert JP; Cooper A; Karagiannis D; Hatlebakk J; Agréus L; Jablonowski H; Tafalla M
Curr Med Res Opin; 2009 Nov; 25(11):2777-84. PubMed ID: 19785512
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and precipitating factors of gastroesophageal reflux disease in a young population of Tabriz, Northwest of Iran.
Somi MH; Farhang S; Mirinezhad K; Jazayeri E; Nasseri-Moghaddam S; Moayeri S; Yasrebinia S
Saudi Med J; 2006 Dec; 27(12):1878-81. PubMed ID: 17143368
[TBL] [Abstract][Full Text] [Related]
19. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States.
Brook RA; Wahlqvist P; Kleinman NL; Wallander MA; Campbell SM; Smeeding JE
Aliment Pharmacol Ther; 2007 Sep; 26(6):889-98. PubMed ID: 17767473
[TBL] [Abstract][Full Text] [Related]
20. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
